| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Kris Pauwels | Q41875108 |
| P2093 | author name string | K Broersen | |
| E Hubin | |||
| N A J van Nuland | |||
| P2860 | cites work | Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease | Q22248091 |
| Alzheimer mechanisms and therapeutic strategies | Q22252311 | ||
| Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio | Q24298670 | ||
| Extracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease | Q24300656 | ||
| A comparative analysis of the aggregation behavior of amyloid-β peptide variants | Q24301848 | ||
| Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy | Q24604376 | ||
| A partially folded structure of amyloid-beta(1-40) in an aqueous environment | Q24624608 | ||
| Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils | Q24631702 | ||
| Atomic-Level Characterization of the Ensemble of the Aβ(1–42) Monomer in Water Using Unbiased Molecular Dynamics Simulations and Spectral Algorithms | Q24633954 | ||
| Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle | Q24644961 | ||
| Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory | Q24645499 | ||
| Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice | Q24649564 | ||
| Aggregation and disaggregation of senile plaques in Alzheimer disease | Q24653813 | ||
| Amyloid beta-protein monomer folding: free-energy surfaces reveal alloform-specific differences | Q24653927 | ||
| The Alzheimer's peptides Abeta40 and 42 adopt distinct conformations in water: a combined MD / NMR study | Q24683781 | ||
| Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease | Q26858870 | ||
| The Alzheimer's peptide a beta adopts a collapsed coil structure in water | Q27626446 | ||
| Atomic structures of amyloid cross-beta spines reveal varied steric zippers | Q27644644 | ||
| Molecular structural basis for polymorphism in Alzheimer's -amyloid fibrils | Q27652925 | ||
| Antiparallel -sheet architecture in Iowa-mutant -amyloid fibrils | Q27677945 | ||
| Structural insights into Aβ42 oligomers using site-directed spin labeling | Q36967253 | ||
| Amyloid-a state in many guises: survival of the fittest fibril fold | Q37016493 | ||
| Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils | Q37028176 | ||
| Intrinsic structural heterogeneity and long-term maturation of amyloid β peptide fibrils | Q37113863 | ||
| Pulsed hydrogen-deuterium exchange mass spectrometry probes conformational changes in amyloid beta (Aβ) peptide aggregation | Q37157432 | ||
| The interaction of beta-amyloid protein with cellular membranes stimulates its own production | Q37171644 | ||
| Aβ monomers transiently sample oligomer and fibril-like configurations: ensemble characterization using a combined MD/NMR approach | Q37191689 | ||
| Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization | Q37199687 | ||
| Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity | Q37209664 | ||
| Structural and functional characterization of two alpha-synuclein strains | Q37305236 | ||
| Structure-neurotoxicity relationships of amyloid beta-protein oligomers | Q37329557 | ||
| Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature. | Q37345689 | ||
| Linking folding and binding | Q37373866 | ||
| Comparison of Alzheimer Abeta(1-40) and Abeta(1-42) amyloid fibrils reveals similar protofilament structures | Q37394004 | ||
| Chaperone signalling complexes in Alzheimer's disease. | Q37486421 | ||
| Signature amyloid β profiles are produced by different γ-secretase complexes | Q37583567 | ||
| Structural disorder in amyloid fibrils: its implication in dynamic interactions of proteins | Q37588016 | ||
| Sleep and Alzheimer disease pathology--a bidirectional relationship | Q37691522 | ||
| Exercise plays a preventive role against Alzheimer's disease | Q37698058 | ||
| The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation? | Q37774042 | ||
| The Toxicity of the Alzheimer's β-Amyloid Peptide Correlates with a Distinct Fiber Morphology | Q50528215 | ||
| gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. | Q51776761 | ||
| Aβ42 oligomers, but not fibrils, simultaneously bind to and cause damage to ganglioside-containing lipid membranes. | Q52612916 | ||
| The solvent protection of alzheimer amyloid-beta-(1-42) fibrils as determined by solution NMR spectroscopy. | Q53272801 | ||
| Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer's abeta(1-40) amyloid fibrils. | Q53289459 | ||
| Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange. | Q53310751 | ||
| Solid-state NMR spectroscopic investigation of Aβ protofibrils: implication of a β-sheet remodeling upon maturation into terminal amyloid fibrils. | Q53317317 | ||
| A new structural model of Aβ40 fibrils. | Q53321830 | ||
| Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro. | Q53381705 | ||
| The common architecture of cross-beta amyloid | Q57219226 | ||
| Structural features of the Abeta amyloid fibril elucidated by limited proteolysis | Q74552318 | ||
| Structural differences in Abeta amyloid protofibrils and fibrils mapped by hydrogen exchange--mass spectrometry with on-line proteolytic fragmentation | Q80019755 | ||
| Quaternary structure of a mature amyloid fibril from Alzheimer's Abeta(1-40) peptide | Q80140617 | ||
| Abeta40 protects non-toxic Abeta42 monomer from aggregation | Q80270099 | ||
| Multiple assembly pathways underlie amyloid-beta fibril polymorphisms | Q81048520 | ||
| Real-time amyloid aggregation monitoring with a photonic crystal-based approach | Q86493645 | ||
| Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct | Q46148419 | ||
| Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy | Q46377191 | ||
| Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis | Q46409791 | ||
| Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. | Q46733868 | ||
| Modification of amyloid-β1-42 fibril structure by methionine-35 oxidation | Q46866720 | ||
| Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease | Q47962016 | ||
| Evidence for age-dependent in vivo conformational rearrangement within Aβ amyloid deposits | Q48114298 | ||
| Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations. | Q48140756 | ||
| Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and design | Q48150029 | ||
| Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research | Q48169675 | ||
| Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity | Q48394799 | ||
| Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype | Q48499517 | ||
| Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure | Q48668545 | ||
| Neuritic pathology and dementia in Alzheimer's disease | Q48679241 | ||
| Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease | Q48770682 | ||
| Resolution of oligomeric species during the aggregation of Aβ1-40 using (19)F NMR. | Q36772928 | ||
| Molecular structures of amyloid and prion fibrils: consensus versus controversy | Q36785202 | ||
| Amyloid-beta aggregation | Q36788949 | ||
| Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer's disease pathology | Q36845156 | ||
| Polymorph-specific kinetics and thermodynamics of β-amyloid fibril growth | Q36938886 | ||
| Membrane and surface interactions of Alzheimer's Aβ peptide--insights into the mechanism of cytotoxicity | Q37896721 | ||
| The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes | Q37979641 | ||
| Metal-associated amyloid-β species in Alzheimer's disease | Q37988268 | ||
| Molecular mechanisms of amyloid oligomers toxicity | Q38005284 | ||
| Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease | Q38016898 | ||
| Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical. | Q38038797 | ||
| Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways | Q38071004 | ||
| The missing link in the amyloid cascade of Alzheimer's disease - metal ions | Q38080353 | ||
| The remarkable conformational plasticity of alpha-synuclein: blessing or curse? | Q38104514 | ||
| On the subject of rigor in the study of amyloid β-protein assembly | Q38131957 | ||
| The triple power of D³: protein intrinsic disorder in degenerative diseases | Q38175719 | ||
| Effect of zinc binding on β-amyloid structure and dynamics: implications for Aβ aggregation | Q38272707 | ||
| A causative link between the structure of aberrant protein oligomers and their toxicity. | Q39750915 | ||
| Fibril fragmentation in amyloid assembly and cytotoxicity: when size matters | Q39890032 | ||
| The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity | Q39951771 | ||
| Size-dependent neurotoxicity of beta-amyloid oligomers. | Q39987923 | ||
| Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. | Q40472233 | ||
| Dynamics of amyloid β fibrils revealed by solid-state NMR. | Q40649097 | ||
| Specific Compositions of Amyloid-β Peptides as the Determinant of Toxic β-Aggregation | Q40652018 | ||
| Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors | Q40752750 | ||
| Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. | Q41621952 | ||
| Structural diversity of ex vivo amyloid fibrils studied by cryo-electron microscopy | Q41630822 | ||
| Structural characterization and inhibition of toxic amyloid-β oligomeric intermediates | Q42086140 | ||
| Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers | Q42161299 | ||
| On the nucleation of amyloid beta-protein monomer folding | Q42215600 | ||
| Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study | Q42492450 | ||
| Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated | Q42546560 | ||
| Amyloid-β peptide fibrils induce nitro-oxidative stress in neuronal cells | Q42880545 | ||
| ANS binding reveals common features of cytotoxic amyloid species | Q43021800 | ||
| Structure of the 21-30 fragment of amyloid beta-protein. | Q43072330 | ||
| Passive immunotherapy rapidly increases structural plasticity in a mouse model of Alzheimer disease | Q43142065 | ||
| Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons. | Q43621866 | ||
| Phosphorylation of amyloid-beta at the serine 26 residue by human cdc2 kinase | Q43811330 | ||
| Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence | Q44356224 | ||
| Beta-amyloid racemized at the Ser26 residue in the brains of patients with Alzheimer disease: implications in the pathogenesis of Alzheimer disease | Q44363055 | ||
| The BRICHOS domain, amyloid fibril formation, and their relationship | Q44681123 | ||
| Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis | Q44700741 | ||
| Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation | Q44769438 | ||
| Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques | Q44772732 | ||
| Transformation of amyloid β(1-40) oligomers into fibrils is characterized by a major change in secondary structure | Q44808414 | ||
| Simulations of monomeric amyloid β-peptide (1-40) with varying solution conditions and oxidation state of Met35: implications for aggregation | Q44992656 | ||
| Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement | Q45086533 | ||
| Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. | Q45249955 | ||
| Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide | Q45738154 | ||
| Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling. | Q45941938 | ||
| Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. | Q45975923 | ||
| Abnormal tau-containing filaments in neurodegenerative diseases | Q34001297 | ||
| Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths | Q34018579 | ||
| Alzheimer's disease and amyloid beta-peptide deposition in the brain: a matter of 'aging'? | Q34021735 | ||
| Interaction of intracellular beta amyloid peptide with chaperone proteins | Q34035607 | ||
| Kinetics of amyloid beta monomer-to-oligomer exchange by NMR relaxation. | Q34043216 | ||
| Racemization: its biological significance on neuropathogenesis of Alzheimer's disease | Q34058929 | ||
| The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42. | Q34089265 | ||
| Neuronutrition and Alzheimer's disease | Q34099466 | ||
| Atomic-resolution dynamics on the surface of amyloid-β protofibrils probed by solution NMR | Q34228566 | ||
| Direct observation of the interconversion of normal and toxic forms of α-synuclein | Q34277399 | ||
| Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism | Q34346440 | ||
| The effect of exercise interventions on cognitive outcome in Alzheimer's disease: a systematic review | Q34365400 | ||
| The aluminium-amyloid cascade hypothesis and Alzheimer's disease | Q34394038 | ||
| Structural disorder throws new light on moonlighting | Q34438504 | ||
| Common core structure of amyloid fibrils by synchrotron X-ray diffraction. | Q34444888 | ||
| The role of apolipoprotein E in Alzheimer's disease | Q34603092 | ||
| Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species | Q34624507 | ||
| Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration | Q34804911 | ||
| Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. | Q34982706 | ||
| Converging concepts of protein folding in vitro and in vivo | Q34984598 | ||
| Advanced glycation end products contribute to amyloidosis in Alzheimer disease | Q35285651 | ||
| Misfolded proteins in Alzheimer's disease and type II diabetes. | Q35535599 | ||
| Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease | Q35604177 | ||
| Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease | Q35774046 | ||
| Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity | Q36098093 | ||
| Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation | Q36238193 | ||
| Molecular plasticity regulates oligomerization and cytotoxicity of the multipeptide-length amyloid-β peptide pool | Q36347659 | ||
| Side-chain dynamics reveals transient association of Aβ(1-40) monomers with amyloid fibers. | Q36502645 | ||
| Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer's disease | Q36521287 | ||
| Hydrogen/deuterium exchange mass spectrometry--a window into amyloid structure | Q36596594 | ||
| Single-molecule imaging reveals aβ42:aβ40 ratio-dependent oligomer growth on neuronal processes | Q36621979 | ||
| Paired beta-sheet structure of an Abeta(1-40) amyloid fibril revealed by electron microscopy | Q36677152 | ||
| Environmental novelty activates β2-adrenergic signaling to prevent the impairment of hippocampal LTP by Aβ oligomers. | Q36682401 | ||
| Characterization of beta-amyloid peptide from human cerebrospinal fluid | Q36754599 | ||
| Atomic View of a Toxic Amyloid Small Oligomer | Q27677948 | ||
| Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue | Q27679935 | ||
| Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide | Q28131750 | ||
| 15N relaxation study of the amyloid beta-peptide: structural propensities and persistence length | Q28250829 | ||
| The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding | Q28294445 | ||
| A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR | Q28387681 | ||
| Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils | Q28388148 | ||
| Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange | Q28394786 | ||
| Aβ peptide fibrillar architectures controlled by conformational constraints of the monomer | Q28744420 | ||
| A specific amyloid-beta protein assembly in the brain impairs memory | Q28854597 | ||
| Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis | Q29547501 | ||
| Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein | Q29547803 | ||
| The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics | Q29614972 | ||
| 3D structure of Alzheimer's amyloid-beta(1-42) fibrils | Q29617475 | ||
| Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils | Q29617476 | ||
| Amyloid deposition as the central event in the aetiology of Alzheimer's disease | Q29619450 | ||
| The thermodynamic stability of amyloid fibrils studied by differential scanning calorimetry | Q30156940 | ||
| Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer | Q30157440 | ||
| Structural polymorphism of Alzheimer Abeta and other amyloid fibrils | Q30319061 | ||
| Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration. | Q30427825 | ||
| Interprotofilament interactions between Alzheimer's Abeta1-42 peptides in amyloid fibrils revealed by cryoEM | Q30438461 | ||
| Structural classification of toxic amyloid oligomers | Q30484255 | ||
| Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques | Q30486499 | ||
| NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox). | Q30666112 | ||
| Hydrogen exchange-mass spectrometry analysis of beta-amyloid peptide structure | Q30731017 | ||
| Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism | Q30873586 | ||
| Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. | Q31078434 | ||
| Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease | Q31939978 | ||
| Solution state characterization of amyloid beta-derived diffusible ligands | Q33266914 | ||
| Alzheimer's disease: clinical trials and drug development | Q33349401 | ||
| Metals, membranes, and amyloid-β oligomers: key pieces in the Alzheimer's disease puzzle? | Q33353753 | ||
| Inflammation, microglia, and Alzheimer's disease | Q33664099 | ||
| Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease | Q33894829 | ||
| Nucleated conformational conversion and the replication of conformational information by a prion determinant | Q33915141 | ||
| Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease. | Q33946695 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| peptide | Q172847 | ||
| membrane protein | Q423042 | ||
| P304 | page(s) | 3507-3521 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
| P1476 | title | Transient dynamics of Aβ contribute to toxicity in Alzheimer's disease | |
| P478 | volume | 71 |
| Q58697561 | A Bifunctional Anti-Amyloid Blocks Oxidative Stress and the Accumulation of Intraneuronal Amyloid-Beta |
| Q57907426 | A Metalloporphyrin-Peptide Conjugate as an Effective Inhibitor of Amyloid-β Peptide Fibrillation and Cytotoxicity |
| Q90620606 | Acetylation of Aβ42 at Lysine 16 Disrupts Amyloid Formation |
| Q38532705 | Alzheimer's Disease, Drosophila melanogaster and Polyphenols. |
| Q92651158 | Amyloid Oligomers, Protofibrils and Fibrils |
| Q54959267 | Amyloid β-peptides 1-40 and 1-42 form oligomers with mixed β-sheets. |
| Q37326344 | Amyloid-β 1-24 C-terminal truncated fragment promotes amyloid-β 1-42 aggregate formation in the healthy brain |
| Q37743448 | Artemisinin protects PC12 cells against β-amyloid-induced apoptosis through activation of the ERK1/2 signaling pathway |
| Q41026207 | Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein |
| Q39223596 | Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes |
| Q92009830 | Deuteron Solid-State NMR Relaxation Measurements Reveal Two Distinct Conformational Exchange Processes in the Disordered N-Terminal Domain of Amyloid-β Fibrils |
| Q41443846 | Diabetes and stem cell function |
| Q42429718 | Editorial: Function and Flexibility: Friend or Foe? |
| Q90387038 | Effect of Post-Translational Modifications and Mutations on Amyloid-β Fibrils Dynamics at N Terminus |
| Q31142609 | Fast Motions of Key Methyl Groups in Amyloid-β Fibrils |
| Q31113985 | Flexibility and Solvation of Amyloid-β Hydrophobic Core |
| Q30764286 | High-speed atomic force microscopy reveals structural dynamics of amyloid β1-42 aggregates |
| Q92926402 | Initial Structural Models of the Aβ42 Dimer from Replica Exchange Molecular Dynamics Simulations |
| Q47343593 | Investigation of the interactions between aptamer and misfolded proteins: From monomer and oligomer to fibril by single-molecule force spectroscopy |
| Q89619677 | Low and High Molecular Weight FGF-2 Have Differential Effects on Astrocyte Proliferation, but Are Both Protective Against Aβ-Induced Cytotoxicity |
| Q40506178 | Modeling the Aggregation Propensity and Toxicity of Amyloid-β Variants. |
| Q49425578 | Monomer Dynamics of Alzheimer Peptides and Kinetic Control of Early Aggregation in Alzheimer's Disease |
| Q39127904 | Nanoscale Structure and Spectroscopic Probing of Aβ1-40 Fibril Bundle Formation |
| Q40048000 | Preferential interaction of the Alzheimer peptide Aβ-(1-42) with Omega-3-containing lipid bilayers: structure and interaction studies |
| Q36244824 | Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure |
| Q36319298 | Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin |
| Q92637852 | Reorientational Dynamics of Amyloid-β from NMR Spin Relaxation and Molecular Simulation |
| Q47590565 | Selenium and Zinc against Aβ25-35-Induced Cytotoxicity and Tau Phosphorylation in PC12 Cells and Inhibits γ-cleavage of APP. |
| Q35755711 | Self-Assembly of Aβ40, Aβ42 and Aβ43 Peptides in Aqueous Mixtures of Fluorinated Alcohols |
| Q37529391 | Sodium selenate regulates the brain ionome in a transgenic mouse model of Alzheimer's disease |
| Q91962728 | Solvent Composition Effects on the Structural Properties of the Aβ42 Monomer from the 3D-RISM-KH Molecular Theory of Solvation |
| Q45063138 | Solvent-Driven Dynamical Crossover in the Phenylalanine Side-Chain from the Hydrophobic Core of Amyloid Fibrils Detected by 2H NMR Relaxation. |
| Q39379363 | Spreading of Pathology in Alzheimer's Disease |
| Q26799897 | The Possible Roles of the Dentate Granule Cell's Leptin and Other Ciliary Receptors in Alzheimer's Neuropathology |
| Q35194588 | The elusive nature and diagnostics of misfolded Aβ oligomers |
Search more.